Ipamorelin + CJC-1295 (No DAC)

A PharmaTech-formulated blend of the two compounds most often paired in the GH-axis literature: Ipamorelin, a selective ghrelin-receptor pentapeptide, and CJC-1295 without DAC, a short-acting GHRH analog. The two act on different receptors of the same axis: CJC-1295 binds pituitary GHRH receptors while Ipamorelin binds GHS-R1a. Combining a GHRH analog with a GHRP is studied because the pair produces a larger and more naturalistic pulse than either compound alone.

GH pulsatility, body composition, sleep quality and recovery — the research areas of its two components.

Lyophilized. Short-acting on the GHRH side; research protocols use more frequent dosing than DAC-conjugated variants.

General reconstitution & storage reference for lyophilized peptides:

1. 1Reconstitute with bacteriostatic water (0.9% benzyl alcohol) rather than plain sterile water — the preservative meaningfully extends usable shelf life.
2. 2In bacteriostatic water, refrigerate at 2–8°C, typically usable for ~28–30 days. In plain sterile water (no preservative): 7–14 days.
3. 3Lyophilized (unmixed) vials are stable at refrigerated or, for some peptides, frozen temperatures for extended periods prior to reconstitution.
4. 4Avoid repeated freeze-thaw cycles, direct light/UV exposure, and heat — these are the primary drivers of peptide degradation.
5. 5Reconstitute gently: inject the water down the inside wall of the vial and swirl — don't shake, which can denature the peptide structure.

Inherits the precautions of both components: effects depend on functioning pituitary GH release, and standard GH-axis cautions apply (insulin sensitivity monitoring, water retention, appetite changes).

• PubMed — Ipamorelin
• PubMed — CJC-1295 / GHRH analogs